Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
PostNL Pharma & Care Belgium from Turnhout, company number BE1006822683, closed financial year 2025 with a result of € -2.6 million after tax. For that financial year PostNL Pharma & Care Belgium recorded revenue of € 22.1 million and equity of € -1.7 million. Compared with financial year 2024, the result moved from € -2 million to € -2.6 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ -1.7 million
▼ € 2.6 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2.6 million
▼ 28 % more loss than in 2024
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € -4.6 million.
People and assets in 2025
117.5
▼ 7.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 8.3 million
▼ 1% vs 2024
€ 70,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 37,046
▼ 57% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4.9 million
▲ 152% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 109 days on average.
€ 1.1 million
▼ 7% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Revenue | € 22,379,869 | € 22,097,383 | ▼ 1% |
| Profit after taxes | € -2,022,788 | € -2,595,409 | ▼ € 572,620 |
| Equity | € 856,617 | € -1,738,792 | ▼ € 2.6 million |
| Total debts | € 3,470,219 | € 6,033,164 | ▲ 74% |
| Retained profit | € -2,022,788 | € -4,618,197 | ▼ € 2.6 million |
| Balance sheet total | € 4,326,836 | € 4,294,372 | ▼ 1% |
| Employees (FTE) | 124.8 | 117.5 | ▼ 7.3 |
Key figures of PostNL Pharma & Care Belgium, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PostNL Pharma & Care Belgium?
What happened at PostNL Pharma & Care Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 2.6 million. Source: NBB ↗
- Sipke Thomas Spoelstra became a director. NBB
- Derk Jan Adelerhof became a director. NBB
- Martijn Daniël Timmermans stepped down as director. NBB
- Christophe Eugène Korthoudt stepped down as director. NBB
- Martijn Daniël Timmermans became a director. NBB
- New establishment in Evergem. KBO
- New establishment in Vilvoorde. KBO
In short
From € 2 million loss in 2024 to € 2.6 million loss in 2025.
Paid € 2,580 in corporate taxes since 2024.
Pays suppliers within 109 days on average.
A new publication or filing at PostNL Pharma & Care Belgium? We notify you, reason included.
Follow PostNL Pharma & Care BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PostNL Pharma & Care Belgium are Sipke Thomas Spoelstra and Derk Jan Adelerhof. The shares are held by PostNL Cargo België bv (100%).
Directors
According to the 2025 annual accounts
since 2025
since 2025
Martijn Daniël Timmermans
Director
Also active at: P.S. Benelux Transport, MIKROPAKKET BELGIUM, PostNL Extra@Home Belgium
since 2025 · until 2025
since 2024 · until 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Bremheidelaan 10
2300 Turnhout
Delori-Maeslaan 2
9940 Evergem
Active since 1 May 2024
Havendoklaan 13
1800 Vilvoorde
Active since 1 May 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →G3 WORLDWIDE (BELGIUM)
€ -4,106 gross margin · 2025
MIKROPAKKET BELGIUM same network
€ 684,696 gross margin · 2025
MyParcel Belgium
€ 824,176 gross margin · 2025
Cheap Cargo Belgium
€ 196,818 gross margin · 2025
PostNL Cargo België same network
€ 483,987 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1006.822.683
- VAT number
- BE 1006.822.683
- Registered office
- Bremheidelaan 10, 2300 Turnhout
- Names & denominations
- PostNL Pharma & Care Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 March 2024
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overige vrachtbehandeling, exclusief in zeehavens
Goederenvervoer over de weg